Stage I Invasive Ductal Carcinoma: Susan's Patient Story

Patient Info: Susan, Female | Stage I

Biomarkers: ER 100% positive; HER2-negative; progesterone receptor result not reported; multigene testing pending

Susan had completed breast surgery for a small early-stage invasive ductal cancer and was awaiting final pathology and genetic results to determine whether radiation, chemotherapy, and long-term endocrine therapy would be needed.

breastcancer.orgRead more →

Stage I Breast Cancer: Kevin's Patient Story

Patient Info: Kevin Jarvis, Male | Stage I

Biomarkers: Genetic testing inconclusive; receptor status not reported

Early male breast cancer treated with mastectomy, sentinel node biopsy, EC chemotherapy, paclitaxel/Taxol, and ongoing daily tamoxifen; latest source text describes good spirits and continued discussion of risk-reducing surgery, but does not explicitly state NED.

Stage II BRCA2 Breast Cancer: Rachel's Patient Story

Patient Info: Rachel Zitofsky, Female, Under 40 | Stage II

Biomarkers: BRCA2 mutation

Rachel was doing well 4.5 years after Stage II breast cancer diagnosis and continued tamoxifen; her BRCA2 result also led her sister to expanded testing and preventive care.

Memorial Sloan KetteringRead more →

Stage II Triple-Negative Breast Cancer: Jennifer's Survivor Story

Patient Info: Jennifer Rancik, Female, Under 40 | Stage II

Biomarkers: BRCA1 mutation; triple-negative breast cancer

Jennifer entered remission in October 2017 after Stage II triple-negative breast cancer treatment and, as of October 2025, reported doing great and being off medications except occasional Zometa.

City of HopeRead more →

HR-Positive Breast Cancer: Sara's Patient Story

Patient Info: Sara Glenn, Female, Under 40

Biomarkers: TP53 mutation / Li-Fraumeni syndrome; ER-positive; HER2-negative

As of June 2025, Sara had completed bilateral mastectomy and reconstruction for ER-positive, HER2-negative breast cancer and was on planned 10-year tamoxifen plus intensive Li-Fraumeni syndrome surveillance for herself and her daughters.

City of HopeRead more →

Rare breast blood-vessel cancer (angiosarcoma) in a teenage girl

Patient Info: Anonymized, Female

Biomarkers: Testing for Li-Fraumeni syndrome and POT1 mutation was inconclusive; no inherited cancer predisposition was established

She remained in remission 3 years after diagnosis and continued annual MRI surveillance of the reconstructed and opposite breasts.

PubMed CentralRead more →

BRCA2 Breast Cancer: Sue's Survivor Story

Patient Info: Sue Friedman, Female, Under 40

Biomarkers: BRCA2 mutation

As of February 2023, Sue Friedman was a long-term breast cancer survivor and founder of FORCE after a BRCA2-associated breast cancer and recurrence; the video is educational and does not state current active disease, NED, or metastatic status for Sue.

The Patient StoryRead more →

Stage II Triple-Negative Breast Cancer: Lucy's Patient Story

Patient Info: Lucy, Female, Under 40 | Stage II

Biomarkers: BRCA1 mutation; triple-negative breast cancer

As of January 2023, Lucy had gone through fertility preservation, chemotherapy, and double mastectomy for Stage II grade 3 triple-negative breast cancer with BRCA1 mutation; no NED or recurrence status was stated.

The Patient StoryRead more →

Triple-Negative Breast Cancer: Stephanie's Survivor Story

Patient Info: Stephanie, Female, Under 40

Biomarkers: ER-negative; PR-negative; HER2-negative; genetic testing negative

As of October 2022, Stephanie had completed treatment for triple-negative breast cancer in January 2022, follow-up tests showed she was cancer-free, and she had no evidence of cancer.

Cleveland ClinicRead more →

Triple-Negative Breast Cancer: Sandra's Survivor Story

Patient Info: Sandra Monsonís, Female, 40s

Biomarkers: Triple-negative breast cancer; BRCA-positive

As of November 2021, Sandra felt healthy and happy after treatment for triple-negative breast cancer, BRCA-positive testing, double mastectomy, implant complication care, external prosthesis, and ovary removal to reduce future cancer risk.

Breast Cancer: Tamara's Survivor Story

Patient Info: Tamara Bumpus, Female

Biomarkers: No specific hereditary breast cancer gene identified; strong family history of breast cancer

As of November 2020, Tamara had successful breast cancer removal and DIEP reconstruction after a 2016 diagnosis, with no specific hereditary gene identified despite a strong family history; recurrence status was not reported.

Cleveland ClinicRead more →

Breast Cancer: Heather's Survivor Story

Patient Info: Heather Kokinda, Female, Under 40

As of March 2018, Heather had completed chemotherapy and double mastectomy, had a clear scan before trying to conceive again, and had given birth to another daughter in July 2017.

Cleveland ClinicRead more →